Skip to main content
Netherlands Heart Journal logoLink to Netherlands Heart Journal
. 2004 May;12(5):230–231.

The FOLLOWPACE study: a prospective study on the (cost-)effectiveness of routine follow-up visits in patients with a pacemaker

JWM van Eck, DE Grobbee, NM van Hemel, KGM Moons
PMCID: PMC2497111  PMID: 25696332

Abstract

In the Netherlands, following implantation of a pacemaker (PM) commonly two or three out-patient follow-up visits are scheduled in the first year to check the patient's health and the PM programme, in order to guarantee optimal patient outcome. Anually, about 200,000 follow-up visits of 20 minutes are performed, in total about 80,000 working hours. The question arises whether and to what extent these regular follow-up checks are truly necessary for the prognosis of the patient and whether they are cost-effective. Yet no information is available on how frequently and extensively a routine PM follow-up visit should be performed. This is probably because it is largely unknown which factors — either documented at PM implantation or at the follow-up visits - predict the occurrence of complications. The FOLLOWPACE study is designed to address these issues. Below we briefly discuss the rationale, objectives and expected results of FOLLOWPACE.

Keywords: complication, cost-effectiveness, follow-up, pace-maker, prediction, prognosis

Full text

PDF
230

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chauhan A., Grace A. A., Newell S. A., Stone D. L., Shapiro L. M., Schofield P. M., Petch M. C. Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol. 1994 Nov;17(11 Pt 2):2012–2015. doi: 10.1111/j.1540-8159.1994.tb03791.x. [DOI] [PubMed] [Google Scholar]
  2. Gillis A. M., Goldman B. S., Yee R., Irwin M. E., Wilson S. L., Ashton T., Philippon F., Fraser J. D., Clavette P., Tyers G. F. Cardiac pacing in Canada in 1998: working towards optimal pacing therapy. Canadian Working Group on Cardiac Pacing. Can J Cardiol. 1998 Sep;14(9):1115–1120. [PubMed] [Google Scholar]
  3. Mounsey J. P., Griffith M. J., Tynan M., Gould F. K., MacDermott A. F., Gold R. G., Bexton R. S. Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial. Br Heart J. 1994 Oct;72(4):339–343. doi: 10.1136/hrt.72.4.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Stofmeel M. A., Kelder J. C., van Hemel N. M., Hooijschuur C. A., Dijk W. A., Grobbee D. E. Geïmplanteerde pacemakers in Nederland, 1984-1997: aantallen, typen en patiëntkenmerken. Ned Tijdschr Geneeskd. 2001 Jun 30;145(26):1254–1258. [PubMed] [Google Scholar]
  5. Sutton R. Guidelines for pacemaker follow up. Report of a British Pacing and Electrophysiology Group (BPEG). Heart. 1996 Nov;76(5):458–460. doi: 10.1136/hrt.76.5.458. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Netherlands Heart Journal are provided here courtesy of Springer

RESOURCES